Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the High Throughput Screening (HTS) Market, and What Are the Key Drivers?

In recent times, the size of the high throughput screening (HTS) market has expanded significantly. The market is projected to increase from $22.98 billion in 2024 to $25.49 billion in 2025, marking a compound annual growth rate (CAGR) of 10.9%. The expansion in the previous period is a result of the growing uptake of high-throughput screening, a boost in research & development expenditure, augmented funding for research, an increase in healthcare spending, and a competitive marketplace.

The market size of high throughput screening (HTS) is anticipated to experience significant expansion in the coming years, with projections placing it at $36 billion in 2029 with a compound annual growth rate (CAGR) of 9.0%. Factors contributing to the growth during the forecast period include the expansion and growth rate of the market itself, strategic maneuvers by leading market players, increasing necessity for disease monitoring and drug discovery, escalating occurrence of chronic illnesses, and an increasing emphasis on the application of ultra high throughput screening (UHTS) techniques. Expected trends in the forecast period include progress in high-throughput screening technology and increased attention towards the adoption of ultra high throughput screening (UHTS) techniques.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the high throughput screening (hts) Market?

Anticipated growth in the high-throughput screening (HTS) market is linked to the increasing incidence of chronic ailments. Chronic diseases are defined as lasting health conditions or illnesses that persist for a considerable duration, generally three months or more. HTS is crucial for rapidly examining a wide array of chemical compounds to identify potential drug candidates that target specific pathways or mechanisms involved in chronic diseases, which is critical for effective long-term disease management. For example, the National Library of Medicine, a US government organization, forecasted in January 2023 that the number of people aged 50 and over in the US with at least one chronic condition would escalate to 142.66 million by 2050. Consequently, the escalating prevalence of chronic diseases is projected to stimulate the expansion of the high-throughput screening (HTS) market.

Request Your Free High Throughput Screening (HTS) Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

Which Companies Are Leading the Charge in Expanding the High Throughput Screening (HTS) Market?

Major companies operating in the high throughput screening (HTS) market are:

• Thermo Fisher Scientific Inc._x000D_

• AstraZeneca Plc_x000D_

• Danaher Corporation_x000D_

• Merck Group_x000D_

• GE HealthCare Technologies Inc._x000D_

What New Trends Are Reshaping the High Throughput Screening (HTS) Market and Its Opportunities?

Leading companies in the high-throughput screening market are creating cutting-edge products like multimode plate readers to provide their clientele with superior and enhanced features. A multimode plate reader (MPR) is a modern lab equipment utilized for high-throughput screening, conducting assessments of chemical and biological samples in microplates by encompassing multiple detection modes for different assays in a singular platform. For example, in February 2023, the US-based MedTech firm, PerkinElmer Inc., introduced the EnVision Nexus system. This system is recognized to be the quickest and most sensitive multimode plate reader in existence. It’s specifically engineered for rigorous high-throughput screening (HTS) applications to accelerate drugs discovery processes. The device presents its unique technology, with features such as dual detectors and optimized reagents like exclusive HTRF and AlphaLISA, along with the most recent reagent kits. It provides researchers an unequalled assay versatility, speed, accuracy, and sensitivity. Featuring convenience options like a plate stacker for either 20 or 50 plates, along with total automation for uninterrupted 24/7 workflow-oriented operations, the EnVision Nexus system enables researchers to effectively scrutinize millions of samples with exceptional efficacy.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the High Throughput Screening (HTS) Market?

The high throughput screening (HTS) market covered in this report is segmented –

1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

Subsegments:

1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

What Are the Top Regions Fueling Growth in the High Throughput Screening (HTS) Market?

North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the High Throughput Screening (HTS) Market?

High-throughput screening (HTS) is a technique employed in drug discovery and various scientific domains to rapidly assess a large number of samples for biological activity. Its purpose is to identify active compounds, antibodies, or genes that modulate specific biological pathways, thereby expediting the drug discovery process.

Browse Through More Similar Reports By The Business Research Company:

Employment Screening Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report

Cellular Health Screening Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

Airport Baggage Screening Systems Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/airport-baggage-screening-systems-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: